Submission of Annual Report of the Company for the F.Y. 2024-25
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nexus Surgical and Medicare Limited submitted its 34th Annual Report for F.Y. 2024-25 to BSE on September 2, 2025. The company reported a sharp improvement in performance, with total revenue rising to Rs. 5.73 crore from Rs. 3.50 crore in the previous year, and profit after tax more than doubling to Rs. 49.74 lakh (from Rs. 21.33 lakh). The board has not recommended any dividend, choosing to conserve resources for future growth. The 34th Annual General Meeting is scheduled for September 26, 2025, to be held via video conferencing. The AGM will consider adopting the audited financials, re-appointing Mr. Ashish Durgaprasad Mishra (who retires by rotation), and appointing M/s. N. Bagaria & Associates as the new Secretarial Auditor for a five-year term starting F.Y. 2025-26 at a proposed fee of Rs. 1 lakh plus taxes. The company's equity shares are listed solely on BSE (Script Code: 538874), with 97.40% already in dematerialized form.
Strong financial turnaround for shareholders, with revenue up roughly 64% and net profit more than doubling year-on-year, though no dividend was declared. The 5-year Secretarial Auditor appointment is a routine governance matter requiring shareholder approval at the upcoming AGM.